Methotrexate (IT)

DRUG2 trials

Sponsors

Therapeutic Advances in Childhood Leukemia Consortium

Conditions

ALL, ChildhoodLeukemia, Myeloid, AcuteLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic Lymphoma, Childhood

Phase 1

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Active, not recruitingNCT03817320

Therapeutic Advances in Childhood Leukemia ConsortiumALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Childhood

Start: 2019-02-12End: 2025-06-30Updated: 2025-06-17

Phase 2

Phase 2 Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."

Not yet recruitingNCT07686107

Therapeutic Advances in Childhood Leukemia ConsortiumLeukemia, Myeloid, Acute

Start: 2026-08-31End: 2030-12-31Target: 24Updated: 2026-07-07

Related Papers

Immunotherapies for Pediatric B-Cell Acute Lymphoblastic Leukemia Patients

Oncology Times2019-04-25